04714Z1
Dilation Celiac Artery to Drug-Coated Balloon with No Device, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | 7 Dilation |
| Body Part | 1 Celiac Artery |
| Approach | 4 Percutaneous Endoscopic |
| Device | Z No Device |
| Qualifier | 1 Drug-Coated Balloon |
Operation Definition
Expanding an orifice or the lumen of a tubular body part
Procedure Overview
This family describes procedures that widen a narrowed or blocked segment of an artery in the leg, pelvis, or abdomen so blood can flow more freely to the tissues those vessels supply. Narrowing in these arteries is commonly caused by atherosclerotic plaque buildup, and when it becomes severe enough, patients may experience leg pain with walking, poor wound healing, or in serious cases, tissue at risk of loss.
The procedure is typically performed using a catheter threaded through the vascular system to the narrowed spot, where a balloon is inflated to press the plaque outward and reopen the lumen. A stent is often left behind to help hold the artery open, though the dilation itself refers to the widening action rather than the device placement. Open surgical techniques that stretch a vessel are also included in this family.
These procedures are generally performed to relieve symptoms of peripheral artery disease, restore circulation to a limb, or address a stenosis found on vascular imaging, and are chosen based on how severe the narrowing is and how much of the artery is affected.
Anatomy & Axis Detail
Celiac Artery
The celiac artery is the first major branch off the abdominal aorta, dividing almost immediately into the hepatic, splenic, and left gastric arteries to supply the foregut organs, and its origin is a recognized site of stenosis from atherosclerosis or median arcuate ligament compression. Dilation of the celiac artery restores luminal diameter at this narrowing, typically via balloon angioplasty with selective stenting when the origin is heavily calcified or the lesion recoils after balloon inflation alone. Because compromised flow through this vessel can affect the liver, spleen, and stomach simultaneously, correcting stenosis here can relieve chronic mesenteric ischemia symptoms not attributable to a single downstream branch. Access is usually retrograde from the femoral or radial artery, with careful catheter positioning at the celiac trunk origin to avoid dissection of this short, wide vessel.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Qualifier: Drug-Coated Balloon
A device qualifier indicating that the angioplasty balloon used to dilate a vessel is coated with an antiproliferative drug intended to reduce restenosis, as opposed to a plain balloon. It is distinguished from Sustained Release, which describes a different drug-delivery mechanism, and from drug-eluting stents, which are a separate device category entirely. Its use should match documentation specifically describing a drug-coated or drug-eluting balloon.
Coding & Documentation
Coders need documentation identifying the specific lower artery segment dilated, the approach used (open, percutaneous, or percutaneous endoscopic), and whether a device such as a stent or an intraluminal device was left in place, since that determines the device value appended to the code. The number of separate lesions treated in different named vessels can also affect how many codes are reported.
A common error is failing to code a separate Dilation for each distinct body part when multiple sites along the same limb are treated, since ICD-10-PCS defines body part values by specific artery segment. Another frequent mistake is omitting or misselecting the device value when a drug-eluting stent, a bare stent, or no device at all was used, since the operative note's wording on device type must be matched precisely to the code table options.